BACKGROUND: Hepatic ischemia/reperfusion (I/R) injury is a principal consideration of trauma, resectional liver surgery, and transplantation. Despite improvements in supportive care, hepatic I/R injury continues to negatively impact patient outcomes because of significant tissue damage and organ dysfunction. CXC chemokines have been implicated as key mediators in the deleterious inflammatory cascade after hepatic I/R and also as important, beneficial regulators of liver recovery and regeneration. As such, their potential to mediate both beneficial and detrimental effects on hepatocytes makes them a key target for therapy. Herein, we provide a review of the inflammatory mechanisms of hepatic I/R injury, with a focus on the divergent functions of CXC chemokines in this response compared with other liver insults, and offer an explanation of this apparent paradox. DATA SOURCES: MEDLINE and PubMed. CONCLUSIONS: CXC chemokines are key mediators of both the inflammatory response to hepatic I/R as well as the recovery from this injury. Their contrasting functions in the regeneration of liver mass after an ischemic insult indicates that therapeutic manipulation of these mediator pathways should differ depending on the surgical milieu.
BACKGROUND:Hepatic ischemia/reperfusion (I/R) injury is a principal consideration of trauma, resectional liver surgery, and transplantation. Despite improvements in supportive care, hepatic I/R injury continues to negatively impact patient outcomes because of significant tissue damage and organ dysfunction. CXC chemokines have been implicated as key mediators in the deleterious inflammatory cascade after hepatic I/R and also as important, beneficial regulators of liver recovery and regeneration. As such, their potential to mediate both beneficial and detrimental effects on hepatocytes makes them a key target for therapy. Herein, we provide a review of the inflammatory mechanisms of hepatic I/R injury, with a focus on the divergent functions of CXC chemokines in this response compared with other liver insults, and offer an explanation of this apparent paradox. DATA SOURCES: MEDLINE and PubMed. CONCLUSIONS: CXC chemokines are key mediators of both the inflammatory response to hepatic I/R as well as the recovery from this injury. Their contrasting functions in the regeneration of liver mass after an ischemic insult indicates that therapeutic manipulation of these mediator pathways should differ depending on the surgical milieu.
Authors: I Singh; G B Zibari; M F Brown; D N Granger; M Eppihimer; H Zizzi; L Cruz; K Meyer; E Gonzales; J C McDonald Journal: Clin Transplant Date: 1999-02 Impact factor: 2.863
Authors: Christoph W Strey; Rosa Maria Marquez-Pinilla; Maciej M Markiewski; Britta Siegmund; Elsie Oppermann; John D Lambris; Wolf O Bechstein Journal: Int J Mol Med Date: 2010-12-28 Impact factor: 4.101
Authors: Nozomu Sakai; Heather L Van Sweringen; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch Journal: Hepatology Date: 2012-01-13 Impact factor: 17.425
Authors: Nozomu Sakai; Thomas Shin; Rebecca Schuster; John Blanchard; Alex B Lentsch; William Thomas Johnson; Dale A Schuschke Journal: Biol Trace Elem Res Date: 2010-06-11 Impact factor: 3.738
Authors: Ryan T Hurt; Paul J Matheson; Jason W Smith; El Rasheid Zakaria; Saad P Shaheen; Craig J McClain; R Neal Garrison Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-09-20 Impact factor: 4.052
Authors: Heather L Van Sweringen; Nozomu Sakai; Amit D Tevar; Justin M Burns; Michael J Edwards; Alex B Lentsch Journal: Hepatology Date: 2011-06-29 Impact factor: 17.425
Authors: Ana-Cristina Dragomir; Richard Sun; Vladimir Mishin; LeRoy B Hall; Jeffrey D Laskin; Debra L Laskin Journal: Toxicol Sci Date: 2012-03-29 Impact factor: 4.849
Authors: Heather L Van Sweringen; Nozomu Sakai; Ralph C Quillin; Jeff Bailey; Rebecca Schuster; John Blanchard; Holly Goetzman; Charles C Caldwell; Michael J Edwards; Alex B Lentsch Journal: Hepatology Date: 2013-01 Impact factor: 17.425